My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
October 2009
Vol. 19 No. 10
Global ID
Annual Meeting Features Timely Global Health Sessions

Eric Goosby, MD, the Obama administration’s global AIDS coordinator, will be the keynote speaker at a symposium on “HIV in the Developing World,” Saturday, Oct. 31, at the 47thAnnual Meeting of IDSA, one of several global health-related sessions scheduled during the meeting, Oct. 29-Nov. 1, in Philadelphia.

During the 10:30 a.m. to noon session, Dr. Goosby will give an update on the U.S. response to the global AIDS epidemic. The United States has led worldwide efforts to curb the spread of HIV/AIDS through the President’s Emergency Plan for AIDS Relief (PEPFAR), first enacted in 2003 and reauthorized last year. Dr. Goosby is charged with implementing the newly reauthorized program. 

The symposium will also feature presentations by Quarraisha Abdool Karim, MD, of the Mandela School of Medicine and Columbia University, and Mark Cotton, MD, of Stellenbosch University in South Africa, who are expected to discuss the deadly intersection of HIV and tuberculosis in the developing world, the importance of reducing HIV infection in women, and HIV treatment and prevention in infants and children. 

A second global health symposium, “HIV and Tuberculosis,” scheduled for Saturday, Oct. 31, 5:30 to 7:30 p.m., will focus on the twin epidemics of HIV and TB. William J. Burman, MD, medical director of the infectious diseases clinic of Denver Public Health, will detail the promise of new TB drugs and how innovations on the horizon could change the treatment of this ancient disease.

Other presenters will include Richard Chaisson, MD, FIDSA, of Johns Hopkins University; Gerald Friedland, MD, FIDSA, of Yale University; and Madhukar Pai, MD, of McGill University. Dr. Friedland will discuss the threat of drug-resistant TB, while Dr. Pai will address the challenge of diagnosing TB infection in HIV-positive patients.

For more information, visit the Annual Meeting website and the online program planner, which you can use to search for specific sessions and speakers, creating your own, day-by-day, personalized itinerary for the meeting. You can also follow IDSA on Twitter for important meeting updates.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Top Stories
From the President: The Importance of Vaccination
IDSA Strengthens Mandatory Influenza Immunization Policy for HCWs
IDSA Journal Club
Patient Care and Science
ACIP Makes Recommendations for HPV Vaccine Use in Males
NIAID Considers Revamp to Clinical Trials Infrastructure, Works to Address Research Barriers
EIN: H1N1 and Seasonal Influenza Vaccination Questions
Drug Approvals, Recalls, Adverse Events Update
Practice Management
How to Bill for H1N1 Vaccine
Global ID
Annual Meeting Features Timely Global Health Sessions
Global Center Calls for Bold New HIV Treatment Targets
Where Will PEPFAR Find 140,000 New Health Care Workers?
Is Europe Moving Ahead of the U.S. on Antimicrobial Resistance Policy Efforts?
Policy and Advocacy
CDC Issues Revised Guidance for Preventing H1N1 in Health Facilities
IDSA Weighs In Regarding New Physician Payment Models
Congress Extends Ryan White Program Until 2013
Your Colleagues
Announcing the New IDSA/HIVMA Board Members
Congratulations to the 2009 Society Award Winners!
IDSA Congratulates the 2009 Joint Research Award Winners
Members on the Move
Welcome, New Members!
Education and Resources
“Ask the Coder” Answers CPT Questions

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.